Showing results (601-610 of 834) with videos related to
Sort By:
Pageof 84
Diabetes Care|July 3, 2025
Effect of SGLT2 Inhibition on Glucosuria During a Hyperglycemic Clamp in HNF1A-MODY (MODY3) and Type 2 DiabetesHenrik Maagensen, Johanne S Jensen, Stine O Høyerup, et al.American Journal of Nephrology|September 14, 2023
Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc AnalysisDaisuke Koya, Stefan D Anker, Luis M Ruilope, et al.Endocrinology, Diabetes & Metabolism|March 1, 2019
Different patterns of second-line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational studyFrederik Persson, Johan Bodegard, Jorma T Lahtela, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 22, 2022
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD studyLuis M Ruilope, Bertram Pitt, Stefan D Anker, et al.European Journal of Heart Failure|March 3, 2022
Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trialGerasimos Filippatos, Bertram Pitt, Rajiv Agarwal, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2016
A urinary proteome-based classifier for the early detection of decline in glomerular filtrationClaudia Pontillo, Lotte Jacobs, Jan A Staessen, et al.Glomerular Diseases|August 15, 2024
Effects of Dapagliflozin in Patients with Membranous NephropathyGlenn M Chertow, Hiddo Lambers Heerspink, Patrick B Mark, et al.The New England Journal of Medicine|May 24, 2024
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesVlado Perkovic, Katherine R Tuttle, Peter Rossing, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 23, 2026
Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trialBrian Rayner, Kenneth W Mahaffey, Johannes F E Mann, et al.Diabetes & Vascular Disease Research|January 3, 2019
Cardiac ventricular sizes are reduced in patients with long-term, normoalbuminuric type 1 diabetes compared to the non-diabetic background populationHenrik Ø Hjortkjær, Tonny Jensen, Jannik Hilsted, et al.Pageof 84